StockData
ANLNasdaqPharmaceutical PreparationsFiscal year ends December 31

Adlai Nortye Group Ltd.

Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 10, 2026
$10.38−0.65 (-5.89%)

Close on Oct 19, 2026

Market cap
–
P/E (TTM)
–
Dividend yield
–

Adlai Nortye Group Ltd. revenue by segment

No segment breakdown reported

Adlai Nortye does not break out revenue by segment, region or product in the tagged data of its filings for this period type.